Hormonal therapy after stem cell transplantation and risk of veno-occlusive disease.
Sica
S
S
Salutari
P
P
Chiusolo
P
P
Cicconi
S
S
Sorá
F
F
Laurenti
L
L
Piccirillo
N
N
Scirpa
P
P
Leone
G
G
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D020249:Hormone Replacement Therapy; D006801:Humans; D007938:Leukemia / Q000628:therapy; D016729:Leuprolide / Q000627:therapeutic use*; D008223:Lymphoma / Q000628:therapy; D008875:Middle Aged; D017697:Premenopause; D012307:Risk Factors; D014592:Uterine Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D014652:Vascular Diseases / Q000517:prevention & control*
D016729:Leuprolide